Global Inhaled Nitric Oxide Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch's in-depth investigation and research, the global Inhaled Nitric Oxide market size will reach 1,473.08 Million USD in 2025 and is projected to reach 2,559.16 Million USD by 2032, with a CAGR of 8.21% (2025-2032). Notably, the China Inhaled Nitric Oxide market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Inhaled nitric oxide (iNO) is a medical treatment that involves delivering small, controlled amounts of nitric oxide gas directly into a patient's lungs to help improve oxygenation and pulmonary blood flow. Nitric oxide is a potent vasodilator, meaning it relaxes and widens blood vessels, particularly in the lungs, which can enhance blood flow to areas with low oxygen levels. This therapeutic approach is commonly used in the treatment of conditions like pulmonary hypertension, acute respiratory distress syndrome (ARDS), and neonatal respiratory failure, particularly in premature infants. By selectively dilating blood vessels in the lungs without affecting other parts of the body, inhaled nitric oxide can improve oxygen exchange and reduce the workload on the heart. It is typically administered through a ventilator or other specialized delivery system and requires careful monitoring to ensure the correct dose is maintained and to avoid potential side effects, such as methemoglobinemia or nitrogen dioxide toxicity.
The major global manufacturers of Inhaled Nitric Oxide include Mallinckrodt, Praxair (Linde plc), Air Liquide, BOC Healthcare (Linde Group), etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Inhaled Nitric Oxide. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Inhaled Nitric Oxide market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Inhaled Nitric Oxide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Inhaled Nitric Oxide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Inhaled Nitric Oxide Include:
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Inhaled Nitric Oxide Product Segment Include:
800 ppm
100 ppm
Others
Inhaled Nitric Oxide Product Application Include:
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Inhaled Nitric Oxide Industry PESTEL Analysis
Chapter 3: Global Inhaled Nitric Oxide Industry Porter's Five Forces Analysis
Chapter 4: Global Inhaled Nitric Oxide Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Inhaled Nitric Oxide Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Inhaled Nitric Oxide Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Inhaled Nitric Oxide Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch's in-depth investigation and research, the global Inhaled Nitric Oxide market size will reach 1,473.08 Million USD in 2025 and is projected to reach 2,559.16 Million USD by 2032, with a CAGR of 8.21% (2025-2032). Notably, the China Inhaled Nitric Oxide market has changed rapidly in the past few years. By 2025, China's market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Inhaled nitric oxide (iNO) is a medical treatment that involves delivering small, controlled amounts of nitric oxide gas directly into a patient's lungs to help improve oxygenation and pulmonary blood flow. Nitric oxide is a potent vasodilator, meaning it relaxes and widens blood vessels, particularly in the lungs, which can enhance blood flow to areas with low oxygen levels. This therapeutic approach is commonly used in the treatment of conditions like pulmonary hypertension, acute respiratory distress syndrome (ARDS), and neonatal respiratory failure, particularly in premature infants. By selectively dilating blood vessels in the lungs without affecting other parts of the body, inhaled nitric oxide can improve oxygen exchange and reduce the workload on the heart. It is typically administered through a ventilator or other specialized delivery system and requires careful monitoring to ensure the correct dose is maintained and to avoid potential side effects, such as methemoglobinemia or nitrogen dioxide toxicity.
The major global manufacturers of Inhaled Nitric Oxide include Mallinckrodt, Praxair (Linde plc), Air Liquide, BOC Healthcare (Linde Group), etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Inhaled Nitric Oxide. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Inhaled Nitric Oxide market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Inhaled Nitric Oxide market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Inhaled Nitric Oxide industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of Inhaled Nitric Oxide Include:
Mallinckrodt
Praxair (Linde plc)
Air Liquide
BOC Healthcare (Linde Group)
Inhaled Nitric Oxide Product Segment Include:
800 ppm
100 ppm
Others
Inhaled Nitric Oxide Product Application Include:
Near-term and Pre-term Infants PPHN
Children and Adult ARDS
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Inhaled Nitric Oxide Industry PESTEL Analysis
Chapter 3: Global Inhaled Nitric Oxide Industry Porter's Five Forces Analysis
Chapter 4: Global Inhaled Nitric Oxide Major Regional Market Size (Sales, Revenue, Price) and Forecast Analysis
Chapter 5: Global Inhaled Nitric Oxide Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 6: Global Inhaled Nitric Oxide Sales, Revenue, Price and Forecast by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 8: Industrial Chain Analysis, Inhaled Nitric Oxide Different Application Market Analysis (Sales and Revenue), Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Inhaled Nitric Oxide Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Inhaled Nitric Oxide Product by Type
- 1.2.1 800 ppm
- 1.2.2 100 ppm
- 1.2.3 Others
- 1.3 Inhaled Nitric Oxide Product by Application
- 1.3.1 Near-term and Pre-term Infants PPHN
- 1.3.2 Children and Adult ARDS
- 1.3.3 Others
- 1.4 Global Inhaled Nitric Oxide Market Revenue and Sales Analysis
- 1.4.1 Global Inhaled Nitric Oxide Revenue Market Size Analysis (2020-2032)
- 1.4.2 Global Inhaled Nitric Oxide Sales Market Size Analysis (2020-2032)
- 1.4.3 Global Inhaled Nitric Oxide Market Sales Price Trend Analysis (2020-2032)
- 1.5 Inhaled Nitric Oxide Market Development Status and Trends
- 1.5.1 Inhaled Nitric Oxide Industry Development Status Analysis
- 1.5.2 Inhaled Nitric Oxide Industry Development Trends Analysis
- 2 Inhaled Nitric Oxide Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Inhaled Nitric Oxide Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Inhaled Nitric Oxide Market Analysis by Country
- 4.1 Global Inhaled Nitric Oxide Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Inhaled Nitric Oxide Revenue and Market Share by Country (2020-2025)
- 4.1.2 Global Inhaled Nitric Oxide Revenue and Market Share Forecast by Country (2026-2032)
- 4.2 Global Inhaled Nitric Oxide Sales Analysis by Country: 2024 VS 2025 VS 2032
- 4.2.1 Global Inhaled Nitric Oxide Sales and Market Share by Country (2020-2025)
- 4.2.2 Global Inhaled Nitric Oxide Sales and Market Share Forecast by Country (2026-2032)
- 4.3 United States Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.4 Germany Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.5 Japan Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.6 China Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.7 France Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.8 U.K. Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.9 South Korea Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.10 Canada Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.11 Italy Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.12 Russia Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.13 Mexico Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.14 Brazil Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.15 India Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.16 Vietnam Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.17 Thailand Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 4.18 South Africa Inhaled Nitric Oxide Market Sales, Revenue and Growth Rate (2020-2032)
- 5 Competition by Manufacturers
- 5.1 Global Inhaled Nitric Oxide Market Sales, Revenue and Sales Price by Key Manufacturers (2021-2025)
- 5.1.1 Global Inhaled Nitric Oxide Market Sales by Key Manufacturers (2021-2025)
- 5.1.2 Global Inhaled Nitric Oxide Market Revenue by Key Manufacturers (2021-2025)
- 5.1.3 Global Inhaled Nitric Oxide Average Sales Price by Manufacturers (2021-2025)
- 5.2 Inhaled Nitric Oxide Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Inhaled Nitric Oxide Competitive Landscape Analysis
- 5.2.2 Global Key Manufacturers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Inhaled Nitric Oxide Market Analysis by Type
- 6.1 Global Inhaled Nitric Oxide Market Revenue Analysis by Type
- 6.1.1 Global Inhaled Nitric Oxide Market Size Analysis by Type: 2024 & 2025 & 2032
- 6.1.2 Global Inhaled Nitric Oxide Revenue and Forecast Analysis by Type (2020-2032)
- 6.2 Global Inhaled Nitric Oxide Market Sales and Forecast Analysis by Type (2020-2032)
- 6.3 Global Inhaled Nitric Oxide Sales Price Trend Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Mallinckrodt
- 7.1.1 Mallinckrodt Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Mallinckrodt Inhaled Nitric Oxide Product Portfolio
- 7.1.3 Mallinckrodt Inhaled Nitric Oxide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.2 Praxair (Linde plc)
- 7.2.1 Praxair (Linde plc) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Praxair (Linde plc) Inhaled Nitric Oxide Product Portfolio
- 7.2.3 Praxair (Linde plc) Inhaled Nitric Oxide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.3 Air Liquide
- 7.3.1 Air Liquide Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Air Liquide Inhaled Nitric Oxide Product Portfolio
- 7.3.3 Air Liquide Inhaled Nitric Oxide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 7.4 BOC Healthcare (Linde Group)
- 7.4.1 BOC Healthcare (Linde Group) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Product Portfolio
- 7.4.3 BOC Healthcare (Linde Group) Inhaled Nitric Oxide Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2021-2025)
- 8 Industry Chain Analysis
- 8.1 Inhaled Nitric Oxide Industry Chain Analysis
- 8.2 Inhaled Nitric Oxide Industry Upstream Supply Analysis
- 8.2.1 Upstream Key Raw Material Supply Analysis
- 8.2.2 Raw Material Suppliers and Contact Information
- 8.3 Inhaled Nitric Oxide Product Downstream Application Analysis
- 8.3.1 Global Inhaled Nitric Oxide Revenue Market Size by Application: 2024 & 2025 & 2032
- 8.3.2 Global Inhaled Nitric Oxide Revenue and Forecast Analysis by Application (2020-2032)
- 8.3.3 Global Inhaled Nitric Oxide Sales and Forecast Analysis by Application (2020-2032)
- 8.4 Inhaled Nitric Oxide Typical Downstream Customers
- 8.5 Inhaled Nitric Oxide Sales Channel Analysis
- 9 Research Findings and Conclusion
- 10 Methodology and Data Source
- 10.1 Methodology/Research Approach
- 10.2 Research Scope
- 10.3 Benchmarks and Assumptions
- 10.4 Date Source
- 10.4.1 Primary Sources
- 10.4.2 Secondary Sources
- 10.5 Data Cross Validation
- 10.6 Disclaimer
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
